Nitinol Laryngeal Stent 

Dextronix has decided to discontinue development of the DexStent-LN program, a Nitinol-based laryngeal stent device intended for the treatment of vocal fold or laryngeal paralysis conditions in pet dogs.  Our team has determined that the company’s research and development efforts are better spent on other technologies within our product development pipeline.